Dr Hani Sabour highlighting treatment options for patients with hypertrophic cardiomyopathy 💡 We’ve moved from symptom relief to targeted therapies—a paradigm shift in HCM care. #CardioTwitter#ACCMidEast@ACCinTouch
The ACC is paving the road to #HealthEquity through advocacy, education, and science, and by acknowledging #SDOH and eliminating disparities.
Find more details here: https://t.co/uHKe2LLfw6
#ACCMidEast#ACCIntl#ACCHealthEquity
@ChrisKramerMD high yield talk (a thread 1/4) AN(O)CA, INOCA & MINOCA – umbrella terms for patients with non-obstructive CAD (<50% stenosis).
•MINOCA: MI + troponin elevation + angina
•INOCA: Ischemia + angina, no troponin
•ANOCA: Angina only
#ACCMidEast@ACCinTouch
As we head toward the closing ceremony and convocation, the final plenary at #ACCMidEast explores successes and challenges in adopting guidelines.
Continue learning in the ACC Guidelines Hub ➡️ https://t.co/7JpXqN0dPF
#ACCIntl
Learn more from the 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing document 👉 https://t.co/zfXTgl2hMB
#ACCMidEast#ACCIntl#JACC@JACCJournals
Congratulations to our #ACCMidEast Abstract Winners for their outstanding research and commitment to advancing cardiovascular care! 👏
We can’t wait to see you again at #ACC26 in New Orleans! #ACCIntl
Challenging TAVI case at #ACCMiddleEast 2025 by Dr. Wail Alkashkari. Valve dislodged into ventricle → hypotension from likely MR. With no surgical backup, operator used snare to reposition into aorta. Preparedness & skill are key.
#TAVI#Cardiology#ACCIntl#ACCEd
Excellent talk by Dr. Hani Sabbour on cardiac amyloidosis 💎—a true masterclass on spotting what’s HIDDEN in plain sight.
🫀 Think Heart failure, Increased wall thickness, Discordant strain, Dark blood pool, Elevated biomarkers, Neuropathy.
#ACCMidEast#Cardiology@JACCJournals
Obesity & CV health at #ACCMidEast 🇦🇪
Semaglutide/tirzepatide give 10–20% loss but need long-term use.
Bariatric surgery achieves 10–30% sustained loss but access & equity limit reach.
2025 #ACC guidance: earlier drug use, no “fail lifestyle first.”
#ACCInt#ACCEd
Excellent talk by João Cavalcante, MD at #ACCMidEast 🇦🇪, moderated by Wael Jaber, MD & Paul Cremer, MD.
AI in imaging shows promise—echo, CMR, CT plaque—but still more questions than answers on outcomes, management, and cost.
#ACCIntl#ACCEd@ACCinTouch@JACCJournals
Excited to be a Social Media Ambassador for the ACC Middle East 2025 in Dubai 🇦🇪 (Oct 3–5), held with the Emirates Cardiac Society.
👉 Follow me for updates.
🔗 https://t.co/iGNwFnoUO2
#ACCMidEast#ACCIntl#ACCEd@ACCinTouch@JACCJournals
#scct2025 great turn out & engagement in the How the experts do it session! Chaired this session with @JohnJeffreyCarr
✅ TAVR life time risk
✅post TAVR halt, endocarditis
✅TMVR planning
✅post LAAO assessment
case review on workstation
@Heart_SCCT@OKhaliqueMD@ChinnaiyanMD
A practical and comprehensive session on the growing and advancing role of Cardiac CT in nonvalvular structural heart interventions at #SCCT2025. Outstanding talks by true experts in the field—translating imaging into impactful patient care.👏 #YesCCT#StructuralHeart@cardioQT